Two cases of post transplant lymphoproliferative disorder in lung transplant recipients

Korean Journal of Internal Medicine

Volumn 19, Issue 4, 2004, Pages 276-281

  Chang, Yoon Soo ^a   Kim, Young ^a   Kim, Do Youn ^a   Kim, Hyung Jung ^a   Ahn, Chul Min ^a   Lee, Doo Yun ^a   Paik, Hyo Chae ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Epstein Barr virus (EBV); Post transplant lymphoproliferative disease (PTLD)

Indexed keywords

ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LUNG BIOPSY; LUNG NODULE; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; ADULT; FEMALE; MALE; VIRUS INFECTION;

ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HUMANS; LUNG TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 14844297724     PISSN: 12263303     EISSN: None     Source Type: Journal    
DOI: 10.3904/kjim.2004.19.4.276     Document Type: Article

References (14)

1. Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS. Post transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877-886, 1991
2. Cohen JI. Epstein-Barr virus lymphoproliterative disease associated with acquired immunodeficiency. Medicine 70:137-160, 1991
3. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post transplantation lymphoproliterative disorders. Blood 85:552-565, 1995
4. Montone KT, Litzky LA, Wurster A, Kaiser L, Bavaria J, Kotloff R, Palevsky H, Pietra GG, Tomaszewski JE. Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation. Surgery 119:544-551, 1996
5. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J. The pathology of post transplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisolne immunosuppression. Am J Pathol 133:173-192, 1988
6. Randhawa PS, Jaffe R, Demetris AJ, Nalesnik M, Starzl TE, Chen YY, Weiss LM. The systemic distribution of Epstein-Barr virus genomes in fatal PTLD: an in situ hybridization study. Am J Pathol 133:1027-1033, 1991
7. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 135:977-987, 1989
8. Bragg DG, Chor PJ, Murray KA, Kjeldsberg CR. Lymphoproliferative disorders of the lung: histopathology, clinical manifestations and imaging features. Am J Roentgenol 163:273-281, 1994
9. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, Simmons RL, Najarian JS. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 306:913-918, 1982
10. Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J. Post transplantation lymphoproliferative disorder in the Epstein-Barr naive lung transplant recipient. Am J Respir Crit Care Med 154:1712-1717, 1996
11. Haque T, Thomas JA, Falk KI, Parratt R, Hunt BJ, Yacoub M, Crawford DH. Transmission of donor Epstein-Barr virus (EBV) in transplanted organs causes lymphoproliferative disease in EBV-seronegative recipients. J Gen Virol 77:1169-1172, 1996
12. Cen H, Breinig MC, Atchison RW, Ho M, McKnight JL. EBV transmission via the donor organ in solid organ transplantation: polymerase chain reaction and restriction fragment length polymorphism analysis of IR2, IR3 and IR4. J Virol 65:976-980, 1991
13. Malouf MA, Chhajed PN, Hopkins P, Plit M, Turner J, Glanville AR. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients. J Heart Lung Transplant 21: 547-554, 2002
14. Levine AM. AIDS-associated malignant lymphoma. Med Clin North Am 76:253-268, 1992